PALISADE BIO, INC. (PALI) Balance Sheet
As of 2026-06-30 (10-Q), PALISADE BIO, INC. (PALI) reported total assets of $127.3M, total liabilities of $5.6M and shareholders' equity of $121.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $125.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PALIPALISADE BIO, INC.Follow PALI — free
—
Price chart with a free account
- Market cap
- 231.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.4 | 7.4 | 16.8 | 12.5 | 4.7 | 15.2 | 6.7 | 5.8 | 5.1 | 0.7 | 10.5 | 12.4 | 12.4 | 9.8 | 133.4 | 125.2 | |
| Short-term investments | — | — | 0.0 | 15.0 | 7.5 | 5.0 | 5.0 | — | — | — | — | — | — | — | — | — | |
| Receivables | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.3 | 0.3 | 0.0 | 0.1 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.5 | |
| Current assets | 3.0 | 7.7 | 17.6 | 28.2 | 13.4 | 20.9 | 12.4 | 6.5 | 5.6 | 0.9 | 11.5 | 14.7 | 13.3 | 10.5 | 134.2 | 127.3 | |
| Total assets | 4.1 | 8.8 | 19.4 | 29.8 | 14.9 | 22.6 | 13.9 | 7.7 | 6.6 | 3.0 | 12.5 | 15.8 | 14.1 | 10.9 | 134.3 | 127.3 | |
| Current liabilities | 2.4 | 1.8 | 5.9 | 4.0 | 6.4 | 7.3 | 1.5 | 1.1 | 1.2 | 8.1 | 2.5 | 3.0 | 2.6 | 3.2 | 4.6 | 5.2 | |
| Long-term debt | — | 0.0 | 4.9 | 8.1 | 3.4 | — | — | — | — | 0.1 | 0.0 | — | — | — | — | — | |
| Short-term debt | — | 0.0 | 2.8 | 0.7 | 4.5 | 3.7 | — | — | — | 1.0 | 0.1 | — | — | — | — | — | |
| Total liabilities | 2.4 | 1.8 | 11.0 | 12.1 | 10.0 | 11.3 | 5.4 | 1.6 | 1.5 | 10.1 | 5.1 | 3.3 | 2.7 | 3.4 | 5.0 | 5.6 | |
| Shareholders' equity | 1.7 | 7.0 | 8.4 | 17.7 | 5.0 | 11.3 | 8.5 | 6.0 | -8.3 | -16.6 | 7.4 | 12.5 | 11.3 | 7.5 | 129.4 | 121.7 |
USD millions · SEC XBRL
PALISADE BIO, INC. — questions
- How much cash does PALISADE BIO, INC. have?
- $125.2M in cash and cash equivalents as of 2026-06-30.
- What are PALISADE BIO, INC.'s total assets?
- $127.3M as of 2026-06-30.
- What is PALISADE BIO, INC.'s shareholders' equity?
- $121.7M as of 2026-06-30.
Every figure on this page comes from PALISADE BIO, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.